in associaton with
15 16 17 Dec. 2020 Virtual Event
JOIN US!
www.sohoitaly.it
Organizing secreteriat
www.proeventi.it [email protected]
20 CME (ECM) HEMATOLOGISTS, ONCOLOGISTS, PATHOLOGIST, BIOLOGISTS
ITALY
Clinical And Biological
School of Multiple Myeloma
promoted by
With the Patronages of in association with
Registration
@sohoitaly
#sohoitalyMM20
15 16 17 Dec. 2020 Virtual Event
Presidents:
Scientific Board:
Scientific Secretariat:
Big Faculty:
in associaton with
ITALY
Clinical And Biological
School of Multiple Myeloma
Cerchione C, Martinelli G, Lee HC, Mateos MV, Anderson KC
Cerchione C, Martinelli G, Lee HC, Mateos MV, Anderson KC
Cerchione C, Martinelli G, Musuraca G, Ronconi S, Ceccolini M
Cerchione C, Martinelli G, Lee HC, Mateos MV, Anderson KC,
Antonioli E, Boccadoro M, Bolli N, Bosi A, Cavo M, Derudas D, Di Raimondo F, Gay F, Gentile M, Lanza F, Larocca A, Martino M, Montefusco V, Olivieri A, Petrucci MT, Romano A, Terragna C, Tosi P, Vacca A, Zamagni E
Day 0 15 Dec 2020
19.00 - 19.30 19.30 - 20.00 20.00 - 20.30 20.30 - 21.00
Day 1
in associaton with
Day 1 16 Dec 2020
Frontal Session
08.30-08.50 Opening and introduction to the project:
C. Cerchione – G. Martinelli
Biology and MRD in Multiple Myeloma N. Bolli – C. Terragna – G. Martinelli 08.50 – 09.10 Molecular pathogenesis of multiple myeloma - N. Bolli 09.10 – 09.30 Minimal Residual Disease Assessment Within the
Bone Marrow of Multiple Myeloma – C. Terragna 09.30 - 09.50 Exploring microinvironment – from biology to
therapy – A. Romano
ITALY Clinical And Biological School of Multiple Myeloma
09.50 – 10.10 Importance of imaging for MRD evaluations – E. Zamagni
Lecture: Future of Multiple Myeloma - K.C. Anderson Lecture: How I manage relapsed/refractory Multiple Myeloma at MD Anderson Cancer Center – H. Lee Lecture: How I manage Smoldering Multiple
Myeloma in 2020 – M.V. Mateos
Lecture: How I manage Multiple Myeloma in
Europe in 2020 – C. Cerchione
10.10 – 10.30 Future perspectives in MRD in Multiple Myeloma:
where are we going? – G. Martinelli 10.30 – 10.50 break
Clinical Session 1 – C. Cerchione – K.C. Anderson – M.V. Mateos 10.50 - 11.10 Present and future of management of frontline
Multiple Myeloma – M.V. Mateos
11.10 – 11.30 Present and future of management of
relapsed/refractory Multiple Myeloma – C. Cerchione
in associaton with
11.50 – 12.10 Antibody-Drug Conjugates (ADCs) and Bispecific
T-cell Engagers (TCEs) in Multiple Myeloma: How are they changing the current panorama – H. Lee
12.10 – 12.20 Discussion
Clinical Session 2 – A. Bosi – A. Olivieri - V. Montefusco Frontline setting
12.20 – 12.40 Transplant-eligible patients: old versus new – V. Montefusco
12.40 - 13.00 Role of consolidation in MM in novel agents era - E. Antonioli
13.00 – 13.20 Role of autologous stem cell transplantation in MM in voler agents era – M.T. Petrucci
13.20 – 13.40 Role of allogenic stem cell transplantation in MM in novel agents era – A. Olivieri
13.40 - 14.00 Estabilished and new options for maintenance therapy - M. Cavo
14.00 – 14.20 Discussion
Clinical And Biological
11.30 – 11.50 Major differences between Europe and USA in the management of Multiple Myeloma – K.C. Anderson
Symposium
in associaton with
Clinical Session 3 – F. Lanza, P. Tosi, D. Derudas Allo and auto transplant: when and why 14.20 - 15.30
Transplant-inelegible patients: old and new options for elderly fit patients - P. Tosi
Transplant-inelegible patients: old and new options 15.50 – 16.10
Extramedullary disease and plasma cell leukemia D. Derudas
16.10 – 16.30
for elderly - unfit/frail patients - A. Larocca
Clinical And Biological School of Multiple Myeloma
16.50 – 17.10 17.10 – 17.30
New Drugs on the Horizon – F. Di Raimondo 17.30 – 17.50
Endothelial cells and dendritic cells as immunosuppressive agents in patients with Multiple Myeloma – A. Vacca 18.10 – 18.30 Discussion – Questions and Answers
CAR-T: lights and shadows in Italy – M. Martino Clinical Session 4 – M. Martino, F. Di Raimondo, A. Vacca
Near future of Multiple Myeloma
Bilancing efficacy and tolerability in novel agents-based treatments – M. Gentile 16.30 – 16.50
How is real world chaging – M. Boccadoro
17.50 – 18.10
in associaton with
Day 2 17 Dec 2020
Young session
Selected oral presentations with project presentations in different categories
Chairs Big Faculty:
Cerchione C, Martinelli G, Lee HC, Mateos MV, Anderson KC, Antonioli E, Boccadoro M, Bolli N, Bosi A, Cavo M, Derudas D, Di Raimondo F, Gay F, Gentile M, Lanza F, Larocca A, Martino M, Montefusco V, Olivieri A, Petrucci MT, Romano A, Terragna C, Tosi P, Vacca A, Zamagni E
1. 08.30-09.00 Biology of Multiple Myeloma 2. 09.00-09.30 MRD tools in Multiple Myeloma
3. 09.30-10.00 Smoldering Multiple Myeloma: present and near future
Clinical And Biological
15 min presentation + 15 min discussion)
4. 10.00 - 10.30 Transplant-eligible patients 10.30 - 11.00 Questions and answers and
discussion for future papers 11.00 - 11.15 break
5. 11.15 - 11.45 Maintenance therapy
6. 11.45 - 12.15 Transplant-inelegible patients - elderly fit patients 7. 12.15 - 12.45 Transplant-inelegible patients elderly -
unfit/frail patients
8. 12.45 - 13.15 Extramedullary disease and plasma cell leukemia 13.15 - 13.45 Questions and answers and
13.45 - 14.45 Symposium
9. 16.00 - 16.30 Relapsed/refractory Multiple Myeloma 1 10. 16.30 - 17.00 Relapsed/refractory Multiple Myeloma 2
11. 17.00 - 17.30 Relapsed/refractory Multiple Myeloma 3 12. 17.30 - 18.00 Novel drug targets and therapies
(After presentations, all projects will be started to be defined, with their teams, objectives and timepoints)
18.30 - 19.00 Questions and answers and
discussion for present and future projects Conclusions and next steps
C. Cerchione, G. Martinelli
in associaton with
discussion for future papers
14.45 - 16.00 Poster walk
18.00 - 18.30 Present and future of European Myeloma Network (EMN) Clinical Trials - F. Gay
Clinical And Biological School of Multiple Myeloma
Introducing anti-CD38 in daily practice of Multiple Myeloma - C. Cerchione
in associaton with
promoted by
supported by an unrestricted educational grant form
Follow us!
Follow us!
#SOHOITALYMM20
The use of social media is extremely important to build a stronger relationship and to improve the interaction between speakers and attendees, so do not forget to use them!
Our official hashtag is #SOHOITALYMM20
You can use it on Facebook, Twitter, Instagram and Linkedin Put your like on our social pages and follow us!
You can tweet with:
@sohoitaly
@sohoyItalyMM20
@SocietyofHemOnc
@IRSTufficiale
@MDAndersonNews
@pro_eventi
@GMartinelli2
@DottorClaudio
@mvmateos
@MaxMartinoRC
ITALY
Clinical And Biological
School of Multiple Myeloma
in association with
Promoted by
